Net loss widens 206% on tax drag as board reevaluates FullBeauty merger terms

Filed June 3, 2026 · Period ending May 2, 2026 · Compared to 10-Q May 29, 2025 · ~2 min read

Key Changes

• high

  Board reevaluating FullBeauty Brands merger announced Dec 2025, citing deteriorating consumer environment and FullBeauty's debt load; still believes in strategic rationale but existing terms not in stockholders' best interests.

  MD&A: FullBeauty merger update verify on EDGAR →
• high

  Net loss widened to $5.9M (-$0.11/share) from $1.9M (-$0.04/share) despite operating loss growing only 69.8%; the 206.3% net-income deterioration driven by $1.6M below-the-line drag (income tax -$1.3M, non-operating/other -$222K), not operations.

  MD&A: Earnings quality verify on EDGAR →
• high

  Meaningful portion of customer base using GLP-1 weight-loss medications, creating dynamic sizing needs and contributing to structural demand shifts; company broadening smaller-size assortments and views as near-term headwind, long-term opportunity.

  MD&A: GLP-1 impact verify on EDGAR →